Mads Utke Werner (Mads U Werner)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Coronary Artery Bypass

Postoperative Pain

Top Venues

Basic & clinical pharmacology & toxicology

Scandinavian journal of pain

Journal of pain research

This page only lists publications with an associated author ORCID identifier.

Publications

Elisabeth Kjaer Jensen, Søren Bøgevig, Torben Balchen, Anders Holten Springborg, Mike Allan Royal, Ida Klitzing Storgaard, Trine Meldgaard Lund, Kirsten Møller, Mads Utke Werner
Dose safety and pharmacodynamics of subcutaneous bupivacaine in a novel extended-release microparticle formulation: A phase 1, dose-ascending study in male volunteers. Basic & clinical pharmacology & toxicology (2024)
Elisabeth Kjær Jensen, Søren Bøgevig, Torben Balchen, Anders Holten Springborg, Mike Allan Royal, Ida Klitzing Storgaard, Trine Meldgaard Lund, Kirsten Møller, Mads Utke Werner
Dose safety and pharmacodynamics of subcutaneous bupivacaine in a novel extended-release microparticle formulation: A phase 1, dose-ascending study in male volunteers. Basic & clinical pharmacology & toxicology 134 (5) (2024)
Akhmedkhan Dubayev, Elisabeth Kjær Jensen, Kenneth Geving Andersen, Martin F Bjurström, Mads Utke Werner
Quantitative somatosensory assessments in patients with persistent pain following groin hernia repair: A systematic review with a meta-analytical approach. PloS one 19 (1) (2024)
Akhmedkhan Dubayev, Elisabeth Kjær Jensen, Kenneth Geving Andersen, Martin F Bjurström, Mads Utke Werner
Quantitative somatosensory assessments in patients with persistent pain following groin hernia repair: A systematic review with a meta-analytical approach. PloS one 19 (1) (2024)
Elisabeth Kjær Jensen, Søren Bøgevig, Torben Balchen, Anders Holten Springborg, Mike Allan Royal, Ida Klitzing Storgaard, Trine Meldgaard Lund, Kirsten Møller, Mads Utke Werner
Dose safety and pharmacodynamics of subcutaneous bupivacaine in a novel extended-release microparticle formulation: A phase 1, dose-ascending study in male volunteers. Basic & clinical pharmacology & toxicology 134 (5) (2024)
Elisabeth Kjær Jensen, Thomas K Ringsted, Joakim M Bischoff, Morten A Petersen, Kirsten Møller, Henrik Kehlet, Mads Utke Werner
Somatosensory Outcomes Following Re-Surgery in Persistent Severe Pain After Groin Hernia Repair: A Prospective Observational Study. Journal of pain research 16 (2023)
Elisabeth Kjær Jensen, Thomas K Ringsted, Joakim M Bischoff, Morten A Petersen, Kirsten Møller, Henrik Kehlet, Mads Utke Werner
Somatosensory Outcomes Following Re-Surgery in Persistent Severe Pain After Groin Hernia Repair: A Prospective Observational Study. Journal of pain research 16 (2023)
Mads Utke Werner, Elisabeth Kjær Jensen
The Harald Breivik lecture 2022. Pathophysiology in persistent severe pain after groin hernia repair. Scandinavian journal of pain 22 (4) (2022)
Lene Jarlbaek, Mads Utke Werner
When surgery prompts discontinuation of opioids. Scandinavian journal of pain 21 (4) (2021)
Elisabeth Kjær Jensen, Emmanuel Bäckryd, Jørgen Hilden, Mads Utke Werner
Trajectories in severe persistent pain after groin hernia repair: a retrospective analysis. Scandinavian journal of pain 21 (1) (2020)
Anna M Wahl, Daniel Bidstrup, Isabel G Smidt-Nielsen, Mads Utke Werner, Ole Hyldegaard, Per Rotbøll-Nielsen
A single session of hyperbaric oxygen therapy demonstrates acute and long-lasting neuroplasticity effects in humans: a replicated, randomized controlled clinical trial. Journal of pain research 12 (2019)